ClinicalTrials.Veeva

Menu

Nasal Intermittent Positive-Pressure Ventilation for Twin Infants With Respiratory Distress Syndrome (twins)

A

Army Medical University of People's Liberation Army

Status

Completed

Conditions

Neonatal Respiratory Distress Syndrome

Treatments

Device: nIPPV
Device: nCPAP

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

In the present study, we hypothesized that primary mode nIPPV initiated shortly after birth would decrease the incidence of intubation or death in twin infants when compared to nCPAP.

Full description

After inclusion of eligible twins infants,one of the twins was supported by nCPAP and another nIPPV.

Enrollment

286 patients

Sex

All

Ages

30 minutes to 6 hours old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Twins
  • Clinical diagnosis of mild-moderate respiratory distress syndrome
  • requiring a fraction of inspired oxigen (FiO2 ) <0.40 to keep oxygen saturation of 90%-95%
  • a chest X-ray suggestive of early stage hyaline membrane disease, (i.e. mild microgranulia and air bronchogram)

Exclusion criteria

  • pneumothorax
  • pneumomediastinum
  • surgical diseases
  • cardiac diseases
  • intraventricular hemorrage
  • major congenital defects

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

286 participants in 2 patient groups

nIPPV
Experimental group
Description:
the infants in the arm were supported by Nasal Intermittent Positive-Pressure Ventilation(nIPPV)
Treatment:
Device: nIPPV
nCPAP
Active Comparator group
Description:
the infants in the arm were supported by Nasal Continuous Positive Airway Pressure(nCPAP)
Treatment:
Device: nCPAP

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems